Diseases, Conditions, Syndromes

1.7 million Australians were living with migraine in 2022

Around 2.2 million Australians were living with a long-term neurological condition in 2022 with migraine the most common—affecting 77% of people with a neurological condition. Migraine disproportionately affects people ...

Medications

FDA approves Itvisma for spinal muscular atrophy

The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in the survival motor neuron ...

Diseases, Conditions, Syndromes

Research finds new method to reduce infant spinal taps

A simple combination of blood and urine tests may allow many infants with fevers (febrile) to safely avoid lumbar punctures (spinal taps), according to new findings from a major international study published in JAMA. The ...